{"id":17480,"date":"2019-11-08T08:48:32","date_gmt":"2019-11-08T13:48:32","guid":{"rendered":"https:\/\/www.benefitscanada.com\/benefits\/health-benefits\/current-vaccines-could-eradicate-up-to-95-of-all-hpv-related-cancers-138588"},"modified":"2019-11-08T08:48:32","modified_gmt":"2019-11-08T13:48:32","slug":"current-vaccines-could-eradicate-up-to-95-of-all-hpv-related-cancers","status":"publish","type":"post","link":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/2019\/11\/08\/current-vaccines-could-eradicate-up-to-95-of-all-hpv-related-cancers\/","title":{"rendered":"Current vaccines could eradicate up to 95% of all HPV-related cancers"},"content":{"rendered":"\n<div class=\"alignleft clearfix\">\n<div class=\"wp-caption feature-image alignleft\"><img decoding=\"async\" loading=\"lazy\" width=\"316\" height=\"190\" src=\"https:\/\/www.benefitscanada.com\/wp-content\/uploads\/2012\/12\/vaccine-needle-drug-e1537388790837.jpg\" class=\"attachment-feature size-feature wp-post-image\" alt title=\"Current vaccines could eradicate up to 95% of all HPV-related cancers\"> <\/div>\n<\/div>\n<p class=\"byline\"><span>Cassandra Williamson-Hopp<\/span>&nbsp;|&nbsp;November 8, 2019<\/p>\n<p>Only eight per cent of&nbsp;Canadian women who are eligible for&nbsp;a vaccine that covers nine strains of&nbsp;the human papillomavirus are actually receiving it.<\/p>\n<p>While one&nbsp;barrier is a&nbsp;lack of knowledge among&nbsp;health-care professionals and patients alike, another is the lack of coverage in group benefits plans, said Dr. Angel Chu, an infectious diseases physician at Foothills Medical Centre, during a session at&nbsp;<em>Benefits Canada<\/em>\u2019s 2019 Calgary Drug Trends Summit on Oct. 24.<\/p>\n<p>\u201cThat\u2019s one of the biggest frustrations because these are patients at high risk of cancers and we have the tools, but they just can\u2019t get it because of financial barriers.\u201d<\/p>\n<p><strong>Read:&nbsp;<a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.benefitscanada.com%2Fnews%2Fhow-hpv-is-causing-more-than-just-cervical-cancer-118802&amp;data=02%7C01%7Ccassandra.williamson-hopp%40tc.tc%7C5ca7636ab6084ecec37e08d763077ece%7Ca3d5bec9241441cfa8da9efc4cd4ea22%7C0%7C1%7C637086756155618080&amp;sdata=kmCVOvY4BDZnsL%2B6FDv1yvBMEgzJVSfyypsW7slvHaY%3D&amp;reserved=0\">How HPV is causing more than just cervical cancer<\/a><\/strong><\/p>\n<p>Every day, nine Canadian women are diagnosed with cervical cancer and three lose their lives to the disease, said Dr. Chu, noting the&nbsp;No. 1 risk factor for the cancer is HPV. It\u2019s estimated that about 400,000 women will have&nbsp;an abnormal pap smear each year, while one in 149 will&nbsp;be diagnosed with cervical cancer and one in 478 will die from it.&nbsp;<\/p>\n<p>HPV is&nbsp;essentially a&nbsp;sexually transmitted cancer, she said, and it\u2019s estimated that eight out of every 10 Canadians will get an HPV infection at some point in their lives. In 2016, the Canadian Cancer Society estimated that 4,400 Canadians were diagnosed with an HPV-related cancer&nbsp;\u2014&nbsp;broken down by females (64 per cent) and males (36 per cent).&nbsp;Globally, HPV is responsible for&nbsp;84 per cent of anal cancers, 70 per cent of vaginal cancers and high rates of both penile and oropharyngeal cancers in men.&nbsp;<\/p>\n<p>\u201cThe traditional thinking is that HPV is a disease mainly seen in women,\u201d said Dr. Chu. \u201cBut in fact, one in three HPV-related cancers actually occur in males.\u201d<\/p>\n<p>The infection also causes genital warts, she added, noting&nbsp;this has a great impact on workplace productivity as the median duration for an episode of warts is 125 days. A patient will need to take time off work, every week, for several weeks or months to receive treatment.<\/p>\n<p><strong>Read:&nbsp;<a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.benefitscanada.com%2Fnews%2Fhighlighting-the-role-of-vaccines-in-preventing-hpv-related-cancer-127240&amp;data=02%7C01%7Ccassandra.williamson-hopp%40tc.tc%7C5ca7636ab6084ecec37e08d763077ece%7Ca3d5bec9241441cfa8da9efc4cd4ea22%7C0%7C1%7C637086756155628077&amp;sdata=p9XHt%2FxE9kdxz3MdVXmhXuoaOX2rw%2FKleKt4LiV1UQo%3D&amp;reserved=0\">Highlighting the role of vaccines in preventing HPV-related cancer<\/a><\/strong><\/p>\n<p>\u201cWe don\u2019t actually know what causes other cancers . . . but with cervical cancer, we know with virtually 100 per cent certainty that it\u2019s caused by an infection. So if we can somehow prevent that infection, we can actually prevent all these cancers from happening. And we currently have the tools to do that with HPV vaccines.\u201d<\/p>\n<p>Currently, a vaccine is available that covers nine strains of HPV and prevents 85 to 95 per cent of all HPV-related cancers, said Dr. Chu.<\/p>\n<p>Among those&nbsp;who are vaccinated, there\u2019s been a 90 per cent decline in HPV infections and genital warts, a 45 per cent decline in low-grade abnormal&nbsp;pap smears and an 85 per cent reduction in cervical pre-cancerous changes, she added. \u201cIf we can prevent 85 per cent of cervical pre-cancers, we can extrapolate that in the future; these women are no longer going to be developing cervical cancers. It\u2019s been a hugely successful vaccine worldwide.\u201d<\/p>\n<p>For plan sponsors,&nbsp;a lot of tools&nbsp;exist to help join this fight, said Dr. Chu. \u201cCertain facilitators to&nbsp;[increase the uptake of] vaccination include onsite&nbsp;. . . clinics; having information sheets, media campaigns or publishing on a company\u2019s website about health and wellness; talking about HPV disease; and encouraging employees to get vaccinated.\u201d<\/p>\n<p><strong>Read more coverage of the <a href=\"https:\/\/www.benefitscanada.com\/?p=138624&amp;preview=true\">2019 Calgary Drug Trends Summit<\/a>.<\/strong><\/p>\n<p> <a href=\"https:\/\/www.benefitscanada.com\/benefits\/health-benefits\/current-vaccines-could-eradicate-up-to-95-of-all-hpv-related-cancers-138588\">Read the full article at BenefitsCanada.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cassandra Williamson-Hopp&nbsp;|&nbsp;November 8, 2019 Only eight per cent of&nbsp;Canadian women who are eligible for&nbsp;a vaccine that covers nine strains of&nbsp;the human papillomavirus are actually receiving it. While one&nbsp;barrier is a&nbsp;lack of knowledge among&nbsp;health-care professionals&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/17480"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=17480"}],"version-history":[{"count":0,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/17480\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=17480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=17480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=17480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}